Board appointment at Fina Technologies
This article was originally published in Scrip
Fina Technologies (US), a spin-off from Gene Network Sciences, has appointed Dr Christopher Ahlberg to its board of directors. He was previously executive vice-president of Tibco and president of Tibco's Spotfire division.
You may also be interested in...
Due to strained resources and the slew of emergency use authorizations being requested by sponsors because of the COVID-19 crisis, the agency will now periodically publish Notices of Availabilities in the Federal Register instead of publishing immediately as the EUAs are handed out. However, companies will still get their NOA letters and can start marketing their products, and the agency will post the announcements sooner on its website.
Diabetes-care company Bigfoot Biomedical announced it raised $55m in a Series C round to support US FDA submission for its insulin delivery system.
The US FDA released three device-related close-out letters in May.